• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Option Care Health Inc.

    2/9/22 10:24:48 AM ET
    $OPCH
    Medical/Nursing Services
    Health Care
    Get the next $OPCH alert in real time by email
    SC 13G 1 filing.txt SCHEDULE 13G Amendment No. 0 OPTION CARE HEALTH INC COMMON STOCK Cusip #68404L201 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #68404L201 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 2,855,459 Item 6: 0 Item 7: 16,790,671 Item 8: 0 Item 9: 16,790,671 Item 11: 9.334% Item 12: HC Cusip #68404L201 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 16,790,671 Item 8: 0 Item 9: 16,790,671 Item 11: 9.334% Item 12: IN Item 1(a). Name of Issuer: OPTION CARE HEALTH INC Item 1(b). Address of Issuer's Principal Executive Offices: 3000 LAKESIDE DR, SUITE 300N BANNOCKBURN, IL 60015 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 68404L201 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 16,790,671 (b) Percent of Class: 9.334% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 2,855,459 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 16,790,671 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of OPTION CARE HEALTH INC. No one other person's interest in the COMMON STOCK of OPTION CARE HEALTH INC is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 8, 2022 Date /s/ Kevin M. Meagher Signature Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 28, 2018, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on October 9, 2018, accession number: 0000315066-18-002414. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management & Research Company LLC * IA Fidelity Management Trust Company BK Strategic Advisers LLC IA * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. Neither FMR LLC nor Abigail P. Johnson has the sole power to vote or direct the voting of the shares owned directly by the various investment companies registered under the Investment Company Act ("Fidelity Funds") advised by Fidelity Management & Research Company LLC ("FMR Co. LLC"), a wholly owned subsidiary of FMR LLC, which power resides with the Fidelity Funds' Boards of Trustees. FMR Co. LLC carries out the voting of the shares under written guidelines established by the Fidelity Funds' Boards of Trustees. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on February 8, 2022, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of OPTION CARE HEALTH INC at December 31, 2021. FMR LLC By /s/ Kevin M. Meagher Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 28, 2018, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Kevin M. Meagher Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 30, 2018, by and on behalf of Abigail P. Johnson* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on October 9, 2018, accession number: 0000315066-18-002414.
    Get the next $OPCH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OPCH

    DatePrice TargetRatingAnalyst
    4/30/2025$40.00Neutral → Buy
    UBS
    1/23/2025$26.00 → $35.00Hold → Buy
    Jefferies
    1/13/2025$26.00 → $33.00Neutral → Buy
    BofA Securities
    12/5/2024$26.00Neutral
    UBS
    11/4/2024$27.00Buy → Neutral
    Goldman
    10/31/2024$38.00 → $26.00Buy → Hold
    Jefferies
    10/30/2024$43.00 → $29.00Buy → Neutral
    BofA Securities
    7/16/2024$36.00Mkt Outperform
    JMP Securities
    More analyst ratings

    $OPCH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kraemer Harry M Jansen Jr bought $969,031 worth of shares (43,000 units at $22.54), increasing direct ownership by 15% to 326,334 units (SEC Form 4)

    4 - Option Care Health, Inc. (0001014739) (Issuer)

    11/13/24 5:27:03 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    Kraemer Harry M Jansen Jr bought $1,104,352 worth of shares (35,000 units at $31.55), increasing direct ownership by 15% to 269,528 units (SEC Form 4)

    4 - Option Care Health, Inc. (0001014739) (Issuer)

    2/28/24 4:41:59 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    Bierbower Elizabeth D bought $79,110 worth of shares (3,000 units at $26.37), increasing direct ownership by 29% to 13,515 units (SEC Form 4)

    4 - Option Care Health, Inc. (0001014739) (Issuer)

    11/1/23 5:09:51 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    $OPCH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Option Care Health upgraded by UBS with a new price target

    UBS upgraded Option Care Health from Neutral to Buy and set a new price target of $40.00

    4/30/25 7:24:45 AM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    Option Care Health upgraded by Jefferies with a new price target

    Jefferies upgraded Option Care Health from Hold to Buy and set a new price target of $35.00 from $26.00 previously

    1/23/25 7:51:53 AM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    Option Care Health upgraded by BofA Securities with a new price target

    BofA Securities upgraded Option Care Health from Neutral to Buy and set a new price target of $33.00 from $26.00 previously

    1/13/25 12:17:48 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    $OPCH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Maggio Nicole was granted 7,167 shares, increasing direct ownership by 37% to 26,476 units (SEC Form 4)

    4 - Option Care Health, Inc. (0001014739) (Issuer)

    8/8/25 4:23:53 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    GC & Corporate Secretary Smyser Collin covered exercise/tax liability with 10,713 shares and converted options into 11,196 shares, increasing direct ownership by 0.62% to 79,002 units (SEC Form 4)

    4 - Option Care Health, Inc. (0001014739) (Issuer)

    5/21/25 4:17:53 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    Director Betten Elizabeth Quadros was granted 5,034 shares, increasing direct ownership by 24% to 26,373 units (SEC Form 4)

    4 - Option Care Health, Inc. (0001014739) (Issuer)

    5/19/25 6:28:58 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    $OPCH
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Option Care Health Inc.

    SCHEDULE 13G/A - Option Care Health, Inc. (0001014739) (Subject)

    8/12/25 10:34:26 AM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by Option Care Health Inc.

    10-Q - Option Care Health, Inc. (0001014739) (Filer)

    7/30/25 4:01:23 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    Option Care Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Option Care Health, Inc. (0001014739) (Filer)

    7/30/25 6:58:17 AM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    $OPCH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

    Marks major milestone with completion of enrollment in pivotal Phase 3 NEAT clinical trial evaluating lead asset, eDSP, for the treatment of A-T; topline results expected in first quarter of 2026 Closed financing priced at a premium bringing existing cash position to approximately $35 million; expected to provide runway through Phase 3 topline results and into at least second quarter of 2026 Entered into strategic relationship with Option Care Health to support commercial launch of eDSP in the U.S. Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today provided an

    8/11/25 4:05:00 PM ET
    $OPCH
    $QNCX
    Medical/Nursing Services
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP

    Provides access to broad-reaching nationwide network of specialty pharmacy and ambulatory infusion suites across the U.S. Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced that it has formed a strategic relationship with Option Care Health, Inc. (NASDAQ:OPCH), the nation's largest independent provider of home and ambulatory infusion services, to support the commercial development and efficient launch of Quince's lead asset, encapsulated dexamethasone sodium phosphate (eDSP) in the U.S., assuming positive study results and subsequent regulatory approval.

    8/7/25 8:00:00 AM ET
    $OPCH
    $QNCX
    Medical/Nursing Services
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2025

    BANNOCKBURN, Ill., July 30, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Net revenue of $1,416.1 million, up 15.4% compared to $1,227.2 million in the second quarter of 2024Gross profit of $269.0 million, or 19.0% of net revenue, up 7.9% compared to $249.4 million, or 20.3% of net revenue, in the second quarter of 2024Net income of $50.5 million, compared to net income of $53.0 million, in the second quarter of 20

    7/30/25 7:00:00 AM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    $OPCH
    Leadership Updates

    Live Leadership Updates

    View All

    Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

    Marks major milestone with completion of enrollment in pivotal Phase 3 NEAT clinical trial evaluating lead asset, eDSP, for the treatment of A-T; topline results expected in first quarter of 2026 Closed financing priced at a premium bringing existing cash position to approximately $35 million; expected to provide runway through Phase 3 topline results and into at least second quarter of 2026 Entered into strategic relationship with Option Care Health to support commercial launch of eDSP in the U.S. Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today provided an

    8/11/25 4:05:00 PM ET
    $OPCH
    $QNCX
    Medical/Nursing Services
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    NorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of Managers

    NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, today announced the appointment of Barbara W. Bodem and David Keeling to its Board of Managers, effective February 12, 2024. Following these appointments, the Board will comprise of 8 directors, 5 of whom are non-executive. "We are pleased to welcome Barbara and David to the NorthStar Board," said Stephen Merrick, Executive Chairman of NorthStar. "Barbara's deep experience serving in senior finance and board roles in leading edge pharmaceutical and

    2/27/24 9:00:00 AM ET
    $BMRN
    $ENOV
    $OPCH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Specialties
    Medical/Nursing Services

    Riverbed|Aternity Announces Appointment of New Board of Directors

    New Board Brings Significant and Diverse Experience to Support Company's Growth and Success Riverbed|Aternity (the "Company") today announced that, as part of its recapitalization, which was finalized today, the following seven directors have been appointed to the Company's new Board of Directors (the "Board"). These appointments became effective on December 7, 2021, upon the completion of the Company's recapitalization and voluntary court-supervised process. "We are pleased to welcome our new directors, a group of seasoned, accomplished and respected business leaders who will bring a wide and diverse range of skills to the Riverbed|Aternity Board," said Dan Smoot, President and CEO of Ri

    12/7/21 6:32:00 PM ET
    $MODV
    $OPCH
    Transportation Services
    Consumer Discretionary
    Medical/Nursing Services
    Health Care

    $OPCH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Option Care Health Inc.

    SC 13G - Option Care Health, Inc. (0001014739) (Subject)

    11/8/24 10:46:38 AM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Option Care Health Inc. (Amendment)

    SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)

    2/13/24 5:12:03 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Option Care Health Inc. (Amendment)

    SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)

    9/11/23 1:33:44 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    $OPCH
    Financials

    Live finance-specific insights

    View All

    Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2025

    BANNOCKBURN, Ill., July 30, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Net revenue of $1,416.1 million, up 15.4% compared to $1,227.2 million in the second quarter of 2024Gross profit of $269.0 million, or 19.0% of net revenue, up 7.9% compared to $249.4 million, or 20.3% of net revenue, in the second quarter of 2024Net income of $50.5 million, compared to net income of $53.0 million, in the second quarter of 20

    7/30/25 7:00:00 AM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    Option Care Health to Announce Second Quarter 2025 Financial Results and Host Conference Call

    BANNOCKBURN, Ill., June 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2025 on Wednesday, July 30, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI6761a41f2d314134ba5d574509278b8d. The call can also be accessed via a liv

    6/25/25 4:05:00 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2025

    BANNOCKBURN, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenue of $1,333.0 million, up 16.3% compared to $1,146.1 million in the first quarter of 2024Gross profit of $263.1 million, or 19.7% of net revenue, up 10.3% compared to $238.5 million, or 20.8% of net revenue, in the first quarter of 2024Net income of $46.7 million, compared to net income of $44.8 million, in the first quarter of 2024 and diluted

    4/29/25 7:00:00 AM ET
    $OPCH
    Medical/Nursing Services
    Health Care